← Back to Clinical Trials
Recruiting NCT06753344

NCT06753344 Youth Promotion of Resilience Involving Mental E-health

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06753344
Status Recruiting
Phase
Sponsor University of British Columbia
Condition Mental Well-being
Study Type INTERVENTIONAL
Enrollment 1,800 participants
Start Date 2025-01-10
Primary Completion 2028-03-31

Eligibility & Interventions

Sex All sexes
Min Age 15 Years
Max Age 16 Years
Study Type INTERVENTIONAL
Interventions
Intervention app

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 1,800 participants in total. It began in 2025-01-10 with a primary completion date of 2028-03-31.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

There is a critical gap in access to mental health promotion, prevention and support among youth worldwide, especially in low and middle-income countries like Vietnam. The Y-PRIME Study aims to respond to this gap by co-designing with Vietnamese youth a mobile app that delivers life skills and self-management skills intervention to promote mental well-being in grade 10 Vietnamese students. Working with the Vietnam Youth Advisory Council (V-YAC) to adapt and co-design the intervention and app ensure that the intervention will be culturally appropriate and relevant to Vietnamese youth. The goal of the current phase is to test this intervention with grade 10 students across three provinces (Hanoi, Thai Binh, and Hung Yen) to assess: 1. Whether the app helps to improve mental well-being and resilience among youth in Vietnam and helps to reduce factors that might increase the risk of poor mental well-being, like stress related to school and other pressures 2. Whether the app can be delivered in Vietnamese schools 3. Whether Vietnamese youth and school staff think the app is appropriate and appealing for youth in order to scale-up the model across the country The control group (meaning they do not have access to the app-based intervention) will complete the outcome survey at baseline, 6 months, and 12 months. After 12 months, they will gain access to the intervention app (at the same time as the experimental group) but no more data will be collected. The intervention group will use the app at their own pace for 1 year while completing the same survey at baseline, 6 months, and 12 months marks. Afterwards, students and school health staff will be invited to a focus group discussion to talk about their experience using the app.

Eligibility Criteria

Inclusion Criteria: * Enrolled in grade 10 of participating secondary schools * Have access to a smartphone * Provided informed assent to participate * Parent of participant provided informed consent for their child to participate Exclusion Criteria: * Not in grade 10 * Not enrolled in participating secondary schools * Not have access to a smartphone * Not provided assent * Parent did not provide consent

Contact & Investigator

Central Contact

Jill Murphy, PhD

✉ jkmurphy@stfx.ca

📞 902-867-5407

Principal Investigator

Raymond Lam, MD

PRINCIPAL INVESTIGATOR

University of British Columbia

Frequently Asked Questions

Who can join the NCT06753344 clinical trial?

This trial is open to participants of all sexes, aged 15 Years or older, up to 16 Years, studying Mental Well-being. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06753344 currently recruiting?

Yes, NCT06753344 is actively recruiting participants. Contact the research team at jkmurphy@stfx.ca for enrollment information.

Where is the NCT06753344 trial being conducted?

This trial is being conducted at Hanoi, Vietnam.

Who is sponsoring the NCT06753344 clinical trial?

NCT06753344 is sponsored by University of British Columbia. The principal investigator is Raymond Lam, MD at University of British Columbia. The trial plans to enroll 1,800 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology